These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
711 related articles for article (PubMed ID: 29135438)
1. Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts. Matilla-Santander N; Valvi D; Lopez-Espinosa MJ; Manzano-Salgado CB; Ballester F; Ibarluzea J; Santa-Marina L; Schettgen T; Guxens M; Sunyer J; Vrijheid M Environ Health Perspect; 2017 Nov; 125(11):117004. PubMed ID: 29135438 [TBL] [Abstract][Full Text] [Related]
2. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort. Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208 [TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study. Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703 [TBL] [Abstract][Full Text] [Related]
4. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study. Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937 [TBL] [Abstract][Full Text] [Related]
5. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study. Webster GM; Venners SA; Mattman A; Martin JW Environ Res; 2014 Aug; 133():338-47. PubMed ID: 25019470 [TBL] [Abstract][Full Text] [Related]
6. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study. Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720 [TBL] [Abstract][Full Text] [Related]
7. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy. Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787 [TBL] [Abstract][Full Text] [Related]
8. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort. Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032 [TBL] [Abstract][Full Text] [Related]
9. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study. Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199 [TBL] [Abstract][Full Text] [Related]
10. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425 [TBL] [Abstract][Full Text] [Related]
11. Exposure to organophosphorus and organochlorine pesticides, perfluoroalkyl substances, and polychlorinated biphenyls in pregnancy and the association with impaired glucose tolerance and gestational diabetes mellitus: The MIREC Study. Shapiro GD; Dodds L; Arbuckle TE; Ashley-Martin J; Ettinger AS; Fisher M; Taback S; Bouchard MF; Monnier P; Dallaire R; Morisset AS; Fraser W Environ Res; 2016 May; 147():71-81. PubMed ID: 26852007 [TBL] [Abstract][Full Text] [Related]
12. Association of serum levels of perfluoroalkyl substances with gestational diabetes mellitus and postpartum blood glucose. Wang Y; Zhang L; Teng Y; Zhang J; Yang L; Li J; Lai J; Zhao Y; Wu Y J Environ Sci (China); 2018 Jul; 69():5-11. PubMed ID: 29941268 [TBL] [Abstract][Full Text] [Related]
13. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort. Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253 [TBL] [Abstract][Full Text] [Related]
14. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010. Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082 [TBL] [Abstract][Full Text] [Related]
15. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort. Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250 [TBL] [Abstract][Full Text] [Related]
16. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health. Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000 [TBL] [Abstract][Full Text] [Related]
17. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women. Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J; Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892 [TBL] [Abstract][Full Text] [Related]
18. Prenatal Exposure to Perfluoroalkyl Substances and Adiposity in Early and Mid-Childhood. Mora AM; Oken E; Rifas-Shiman SL; Webster TF; Gillman MW; Calafat AM; Ye X; Sagiv SK Environ Health Perspect; 2017 Mar; 125(3):467-473. PubMed ID: 27352404 [TBL] [Abstract][Full Text] [Related]
19. Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function. Fleisch AF; Rifas-Shiman SL; Mora AM; Calafat AM; Ye X; Luttmann-Gibson H; Gillman MW; Oken E; Sagiv SK Environ Health Perspect; 2017 Mar; 125(3):481-487. PubMed ID: 27586368 [TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children. Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]